Pages that link to "Q83116457"

The following pages link to The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial (Q83116457):

Displaying 50 items.

• Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE) (Q26744756) (← links)
• Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladder (Q26747775) (← links)
• Bacillus Calmette-Guérin (BCG) Treatment Failures in Non-Muscle Invasive Bladder Cancer: What Truly Constitutes Unresponsive Disease (Q27011829) (← links)
• Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis (Q28073378) (← links)
• Bladder cancer: narrowing the gap between evidence and practice (Q30362052) (← links)
• Bladder cancer: new TUR techniques (Q33414689) (← links)
• Narrow Band Imaging Cystoscopy and Bipolar Plasma Vaporization for Large Nonmuscle-invasive Bladder Tumors—Results of a Prospective, Randomized Comparison to the Standard Approach (Q34161175) (← links)
• Saudi oncology society and Saudi urology association combined clinical management guidelines for urothelial urinary bladder cancer. (Q34437299) (← links)
• GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer (Q34539958) (← links)
• Saudi Oncology Society clinical management guidelines for urinary bladder cancer. (Q34997367) (← links)
• Second transurethral resection in T1G3 bladder tumors - Selectively avoidable? (Q35125712) (← links)
• Best practice in the treatment of nonmuscle invasive bladder cancer (Q35688392) (← links)
• Three-gene signature predicts disease progression of non-muscle invasive bladder cancer. (Q36121198) (← links)
• The impact of early re-resection in patients with pT1 high-grade non-muscle invasive bladder cancer (Q36217138) (← links)
• CUA guidelines on the management of non-muscle invasive bladder cancer (Q36326208) (← links)
• Results of second transurethral resection for high-grade T1 bladder cancer (Q36481219) (← links)
• The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopy (Q36786491) (← links)
• The optimal management of T1 high-grade bladder cancer. (Q37472570) (← links)
• Contemporary management of low-risk bladder cancer (Q37828064) (← links)
• Bladder tumours: time for a paradigm shift? (Q37868801) (← links)
• Perioperative management of nonmuscle-invasive bladder cancer (Q37911190) (← links)
• Urothelial carcinoma of the bladder: definition, treatment and future efforts (Q37944437) (← links)
• The role of single instillation chemotherapy in patients who receive subsequent bacillus Calmette-Guérin: A retrospective single centre study, and systematic review of the literature (Q38568091) (← links)
• Is 'second-look' (re-staging) transurethral resection of bladder tumours a new standard of care? (Q38636903) (← links)
• Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of Alberta (Q38682443) (← links)
• Guideline of guidelines: non-muscle-invasive bladder cancer (Q39069660) (← links)
• The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line (Q39147858) (← links)
• Optimal timing of radical cystectomy in T1 high-grade bladder cancer (Q39813009) (← links)
• Is restaging transurethral resection necessary in patients with non-muscle invasive bladder cancer and limited lamina propria invasion? (Q40130355) (← links)
• A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer (Q40347829) (← links)
• An evaluation to define the role of repeat transurethral resection in a treatment algorithm for non-muscle-invasive bladder cancer (Q42357046) (← links)
• Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in T a/T1 patients: a randomized two-centre study (Q42694650) (← links)
• Non-muscle invasive bladder cancer: Are epicrises the 'Bermuda Triangle' of information transfer? (Q43208189) (← links)
• Clinical Utility of Fluorescence In Situ Hybridization for Prediction of Residual Tumor After Transurethral Resection of Bladder Urothelial Carcinoma (Q44736576) (← links)
• Bladder cancer. (Q52810295) (← links)
• [Non-muscle-invasive bladder cancer: Information transfer from the clinic to the doctor's office : Results of a questionnaire study and presentation of a software solution]. (Q53026795) (← links)
• Current status of diagnosis and treatment of bladder cancer in China - Analyses of Chinese Bladder Cancer Consortium database. (Q53073693) (← links)
• Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladder 2017. (Q55013973) (← links)
• T1 bladder cancer: current considerations for diagnosis and management (Q57464869) (← links)
• Is there a role for second transurethral resection in pTa high-grade urothelial bladder cancer? (Q58578847) (← links)
• Utility of restage transurethral resection of bladder tumor (Q58593647) (← links)
• The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer (Q64262714) (← links)
• Advances in risk stratification of bladder cancer to guide personalized medicine. (Q64927304) (← links)
• Relook TURBT in superficial bladder cancer: its importance and its correlation with the tumor ploidy (Q81666409) (← links)
• [Therapeutic effect of mitomycin C in the immediate postoperative period in patients with intermediate-risk non-muscle-invasive bladder tumors] (Q82776680) (← links)
• Bladder cancer: Restaging TUR reduces recurrence and progression risk (Q82791559) (← links)
• Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma (Q83655754) (← links)
• Re: Maurizio A. Brausi. Challenging the EAU Guidelines Regarding Early Repeat Transurethral Resection. Eur Urol Suppl 2011;10:e5–7 (Q83760299) (← links)
• [EAU guidelines on non-muscle-carcinoma of the bladder] (Q84179628) (← links)
• Improving urologic cancer care (Q84184626) (← links)